EuroTimes Breaking News
Date Posted 04/01/2010
Alcon Independent Director Committee Reviewing Novartis’ Merger Proposal
Alcon has announced that Novartis has exercised its option to purchase the remaining shares in Alcon owned by Nestle at a weighted average price of US$180 per share in cash.
Upon completion of the purchase, Novartis will own an approximate 77 per cent interest in Alcon.
Alcon also announced that Novartis has submitted a proposal to the Alcon Board of Directors relating to the remaining approximate 23 per cent publicly-held minority interest.
For more information see www.alcon.com.

eTIMES newsletter
eTIMES is a new bi-monthly newsletter with the latest breaking news from the ESCRS and the world of ophthalmology.
Media Guide 2010
Results from our readership survey plus information about advertising in EuroTimes
Podcasts
Eye Contact features interviews with key opinion leaders in the world of ophthalmology
Tuesday, 07 September 2010
www.eurotimes.org